Medidata and Tigermed Strengthen 13-Year Partnership to Advance Global Clinical Trial Technology
核心洞察
Medidata and Tigermed have extended their long-standing partnership to enhance clinical trial processes from early-phase studies to post-marketing surveillance through advanced cloud-based solutions.
Tigermed has successfully conducted over 300 therapeutic trials using the Medidata Platform (搜索) since 2011, demonstrating proven effectiveness in improving trial efficiency and data-driven decision making.
The expanded collaboration will integrate Medidata AI (搜索) technology and automated data capture capabilities to streamline clinical trial workflows and accelerate treatment delivery globally.
Medidata and Tigermed have announced a significant expansion of their 13-year technology partnership, marking a new chapter in clinical trial innovation. The extended collaboration aims to enhance trial processes across all phases while ensuring regulatory compliance and accelerating treatment delivery to patients worldwide.
Strategic Partnership Enhancement
The partnership builds on a proven track record of success, with Tigermed having conducted more than 300 trials across various therapeutic areas using the Medidata Platform (搜索) since 2011. The extended agreement will deepen the integration of Medidata's cloud-based technology into Tigermed's operational workflow, with a particular focus on automated data capture and trial efficiency optimization.
"Our partnership with Medidata has allowed our customers to make informed, data-driven decisions and achieve milestones faster," said Hao Wu, Executive Director and Co-President of Tigermed. "We are delighted to extend this collaboration and look forward to leveraging more of Medidata's technologies, including Medidata AI (搜索), as we shape the future of clinical trials worldwide."
Technology Integration and Innovation
The Medidata Platform (搜索) serves as a comprehensive digital ecosystem, connecting key stakeholders including contract research organizations (CROs), clinical sites, sponsors, and patients through a secure cloud environment. This integrated approach ensures seamless communication and data flow throughout the clinical trial process.
Edwin Ng, Medidata APAC General Manager and Senior Vice-President, emphasized the evolving role of CROs in the clinical trial landscape: "Tigermed exemplifies the evolving role of CROs in driving efficiencies across the clinical trial process. Through this partnership, we're able to jointly push the boundaries of trial management, improving study experiences, and ultimately delivering better outcomes for patients and sponsors around the world."
Enhanced Clinical Trial Management
The partnership expansion introduces several key technological advancements:
- Integration of Medidata AI capabilities for enhanced data analysis
- Automated data capture systems for improved accuracy and efficiency
- Streamlined workflow processes from early-phase studies to post-marketing surveillance
- Enhanced regulatory compliance measures
- Advanced trial management tools for expedited treatment delivery
This strategic collaboration represents a significant step forward in modernizing clinical trial processes, combining Tigermed's extensive research experience with Medidata's cutting-edge technology platform to advance global clinical research capabilities.